Ocrelizumab Intravenous and Ropinirole Extended-Release Tablets
Determining the interaction of Ocrelizumab Intravenous and Ropinirole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
Generic Name: ropinirole
Brand name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit
Synonyms: Ropinirole, ROPINIRole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ocrelizumab Intravenous-Ropinirole Hydrochloride
- Ocrelizumab Intravenous-Ropinirole Tablets
- Ocrelizumab Intravenous-Ropivacaine
- Ocrelizumab Intravenous-Ropivacaine Hydrochloride
- Ocrelizumab Intravenous-Ropivacaine Injection
- Ocrelizumab Intravenous-Rosac
- Ropinirole Extended-Release Tablets-Ocrevus
- Ropinirole Extended-Release Tablets-Octagam
- Ropinirole Extended-Release Tablets-Octagam Gammagard S/D
- Ropinirole Extended-Release Tablets-Octocaine
- Ropinirole Extended-Release Tablets-Octocaine 100
- Ropinirole Extended-Release Tablets-OctreoScan